Association of atrial fibrillation with mortality and disability after ischemic stroke
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: We determined whether patient characteristics (age, sex, comorbidities), stroke severity, and quality of care explained a proportion of the association between atrial fibrillation (AF) and increased disability and mortality in patients with acute ischemic stroke.
Methods: The study included a prospective cohort of consecutive patients admitted with acute ischemic stroke included in the Registry of the Canadian Stroke Network (July 1, 2003 to March 31, 2008). Multivariable logistic regression analyses were used to determine the magnitude of association between AF and modified Rankin score 4–5 at discharge, 30-day mortality, and 1-year mortality.
Results: There were 10,528 patients admitted with acute ischemic stroke. AF was associated with an increased risk of severe disability and mortality, but the magnitude of association was substantially attenuated in the full multivariable models: modified Rankin score 4–5 at discharge (univariate odds ratio [OR] 1.74, 95% confidence interval [CI] 1.57–1.93; multivariable OR 1.19, 95% CI 1.03–1.36), 30-day mortality (univariate OR 2.52, 95% CI 2.25–2.84; multivariable OR 1.36, 95% CI 1.17–1.58), and 1-year mortality (univariate OR 2.41, 95% CI 2.19–2.66; multivariable OR 1.25, 95% CI 1.10–1.42). Older age and increased stroke severity explained most of the association between AF and poor stroke outcomes. We found no association between AF and poor stroke outcomes in patients receiving therapeutic preadmission oral anticoagulant therapy.
Conclusions: Older age and increased stroke severity explain most of the association between AF and poorer outcomes after acute ischemic stroke. Nonuse of oral anticoagulant therapy represents the most important modifiable care gap to mitigate the association between AF and poor outcomes after ischemic stroke.
GLOSSARY
- AF=
- atrial fibrillation;
- CAD=
- coronary artery disease;
- CHF=
- congestive heart failure;
- CI=
- confidence interval;
- CNS=
- Canadian Neurological Scale;
- DM=
- diabetes mellitus;
- INR=
- international normalized ratio;
- OAC=
- oral anticoagulant;
- OR=
- odds ratio;
- OT=
- occupational therapy;
- PT=
- physiotherapy;
- RCSN=
- Registry of the Canadian Stroke Network
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at www.neurology.org
- Received January 18, 2013.
- Accepted in final form May 28, 2013.
- © 2013 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Risk factors, inpatient care, and outcomes of pneumonia after ischemic strokeO. Finlayson, M. Kapral, R. Hall et al.Neurology, September 21, 2011 -
Articles
Gastrointestinal bleeding after acute ischemic strokeM. J. O'Donnell, M. K. Kapral, J. Fang et al.Neurology, August 06, 2008 -
Articles
Care and outcomes in patients with ischemic stroke with and without preexisting dementiaG. Saposnik, R. Cote, P.A. Rochon et al.Neurology, October 31, 2011 -
Article
Network meta-analysis of patent foramen ovale management strategies in cryptogenic strokeHamidreza Saber, Mohan Palla, Shaghayegh Kazemlou et al.Neurology, June 06, 2018